Patent · US Expired

Pharmaceutical composition of L-DOPA ester

US5840756A · kind A · utility

60Cited by

5References

16Claims

0Family size

Assignees

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · IL
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. · IL

Inventors

Sasson Cohen · Nes Ziona, IL
Sela Yoram · Raanana, IL
Ruth Levy · Skippack, US
Nava Shterman · Netanya, IL
Eldad Melamed · Nes Ziona, IL
Dafna Atlas · 'Anata, IL

Key dates

Filing date	Jul 11, 1996
Grant date	Nov 24, 1998
Priority date	—
Expiry date	Jul 11, 2016

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a pharmaceutical composition contains a thpeutically effective amount of L-DOPA ethyl ester and a carrier which comprises from 5.5 to 98.5% hydroxypropylmethyl cellulose, from 0.25 to 4.5% hydroxypropyl cellulose, and from 1 to 90% of a carboxyvinyl polymer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.